AUS
NZ
UK
CA
USA
IND
Healt
Orthocell’s Securities Placed In Trading Halt, AU$10 Mn Capital Raising Planned
May 28, 2019 10:23 PM AEST| By Team Kalkine MediaOrthocell Limited (ASX: OCC) is a world leading regenerative medicine company based in Murdoch, Australia.? The healthcare sector player develops and commercialises cell therapies and products for the repairment of soft tissue injuries, thus supporti...
PainChek® Signs A BDA With Person Centred Software; Momentum Indicator RSI Off The Charts!
May 28, 2019 07:59 PM AEST| By Team Kalkine MediaPainChek Ltd (ASX: PCK) is an ASX listed healthcare company which uses facial recognition software to detect the presence of facial micro-expressions from a small video of the person, taken from a smartphone in real time. Due to its reproducibility,...
Telix Requested FDA for NDA Meeting; Added 2 New Partners in the US
May 28, 2019 03:48 PM AEST| By Team Kalkine MediaTelix Pharmaceuticals Limited (ASX: TLX) is a global biopharmaceutical company based in Melbourne. The company develops diagnostic and therapeutic products. Its focus is on radiopharmaceuticals or molecularly targeted radiation. TLX globally operates...
All that investors need to know about clinical stage oncology company, Prescient Therapeutics
May 28, 2019 03:44 PM AEST| By Team Kalkine MediaPrescient Therapeutics Limited (ASX: PTX), based in South Melbourne, Australia, is an oncology company (clinical-stage) that develops novel drugs and targeted therapies to treat specific mutations that stimulate cancer and thus, contribute to resista...
THC Global Chairman: THC Is Far Stronger Than It Was 12 Months Ago
May 28, 2019 02:17 PM AEST| By Team Kalkine MediaMedicinal cannabis product company, THC Global Group Limited (ASX: THC) released its chairman address, which is to be presented in the 2019 Annual General Meeting scheduled to be held today, i.e., 28 May 2019. THC Global functions as a ?Farm to Phar...
Dimerix Ltd Issues DMX-200 Manufacturing Update; Commercial Scale Production in FY2020
May 28, 2019 12:39 PM AEST| By Team Kalkine MediaDimerix Limited (ASX: DXB) is a clinical-stage biopharmaceutical company. It develops innovative therapies for medical needs that have not been met with. DXB caters to global markets. Presently, the company is developing its proprietary product, DMX-...
Fisher & Paykel Healthcare Achieved Revenue Milestone of NZ$1 Billion in FY19
May 27, 2019 05:16 PM AEST| By Team Kalkine MediaFisher & Paykel Healthcare Corporation Limited (ASX: FPH) is primarily involved in designing innovative products for respiratory care. The company help patients transition to less acute care settings, help them recover more quickly and provide so...
BARD1 Life Sciences Granted R&D Tax Incentive Refund From ATO
May 27, 2019 04:20 PM AEST| By Team Kalkine MediaBARD1 Life Sciences Limited (ASX: BD1) operates in the medical line of business. The company, based in Australia, is a medical technology company which aims to develop and commercialise non-invasive diagnostic tests towards detecting an early stage c...
Resonance Health’s Current Suite Of Products And Expanding R&D Initiatives
May 27, 2019 03:54 PM AEST| By Team Kalkine MediaAustralia-based Resonance Health (ASX: RHT) is a healthcare sector company which specialises in developing and offering non-invasive medical imaging software and analysis services to clinicians for the diagnosis and management of human diseases; and...
Noxopharm Expands LuPIN Trial On Promising Interim Results That Relate To Veyonda®
May 27, 2019 02:21 PM AEST| By Team Kalkine MediaClinical-Stage drug development company, Noxopharm Limited (ASX: NOX) has announced a notable expansion of its investigator-initiated trial, LuPIN, at the back of encouraging interim results observed to date in LuPIN trial Veyonda? (NOX66) dose-findi...
Federal Court Approved Healthscope’s Takeover by Brookfield’s ANZ Hospitals; CEO Quits
May 27, 2019 02:13 PM AEST| By Team Kalkine MediaHealthscope Limited (ASX: HSO) is a ?healthcare company operating and managing a vast network of clinics, hospitals, and physicians, that provide emergency care, cancer care, pediatric services, pathology tests as well as complex surgeries. There is...
Healthcare Stocks At High Levels-PME & CUV
May 26, 2019 09:30 AM AEST| By Team Kalkine MediaAccording to a ?Health expenditure Australia? report for 2016 ? 2017 by Australian Institute of Health and Welfare (AIHW), Australia spent nearly $181 billion on health which accounts to an astonishing 10% of the entire economy. The real growth, afte...
Starpharma’s DEP® Irinotecan Outperforms Other leading Cancer Drugs
May 24, 2019 11:45 PM AEST| By Team Kalkine MediaStarpharma Holdings Limited (ASX: SPL) is based out of Melbourne. The company has two primary development programs, which are VivaGel? portfolio and DEP? drug delivery. Besides this, it is developing various products internally and others through und...
Antisense Therapeutics: Phase II Clinical Trial Of ATL1102 Is Fully Enrolled Now
May 24, 2019 05:16 PM AEST| By Team Kalkine MediaOn Friday, Antisense Therapeutics Limited (ASX: ANP) announced that Phase II clinical trial of its immunomodulatory therapy, ATL1102 for Duchenne Muscular Dystrophy (DMD) is now fully enrolled. The trial is an open-label six-month dosage trial and is...
2 Healthcare Stocks - LBT, RNO
May 23, 2019 11:44 PM AEST| By Team Kalkine MediaLBT Innovations Limited LBT Innovations Limited (ASX: LBT), established in 2004 and based in Adelaide, Australia, is engaged in the research and development of technologies for the healthcare and laboratory supply markets in Australia, Switzerland,...
A Glimpse at Neuren’s neuroscience drug therapy pipeline
May 23, 2019 03:26 PM AEST| By Team Kalkine MediaA biopharmaceutical company headquartered in Australia, Neuren Pharmaceuticals Limited (ASX: NEU) is engaged in the development of new therapies for ?neurodevelopmental disorders with a high unmet need, characterised by impaired connections and signa...
AFP’s FY19 Performance - What investors need to know?
May 23, 2019 01:50 PM AEST| By Team Kalkine MediaAFT Pharmaceuticals Limited (ASX: AFP) is a growing pharma company with its head office based out of New Zealand. It officially was listed on ASX in December 2015. On 22nd May 2019, the company published its Investor Presentation and Annual Report, c...
Rhythm Biosciences’ QMS Granted ISO Certification
May 23, 2019 01:40 PM AEST| By Team Kalkine MediaRhythm Biosciences Limited (ASX: RHY) is an ASX listed healthcare company which is developing a diagnostic tool for the early detection of colorectal cancer, which causes high mortality rate. It has its lead product, ColoSTAT?, a simple and low-cost...
Oventus Medical’s O2 Vent® Eases Into Largest Dental Group In North Carolina, USA
May 22, 2019 10:59 PM AEST| By Team Kalkine MediaOventus Medical Limited (ASX: OVN) is a healthcare sector company, engaged in the development of oral devices that are used for the therapeutic treatment of breathing disorders, particularly sleep apnea. On 22nd May 2019, Oventus Medical Limited ann...
Sienna Cancer Diagnostics Granted SIEN-NETTM Chinese Patent
May 22, 2019 10:21 PM AEST| By Team Kalkine MediaThe medical technology company, Sienna Cancer Diagnostics Limited (ASX: SDX) is based in Australia. It develops and commercialises innovative cancer related tests. Besides Australia, SDX operates in Asia, The United States, Europe, Latin America. The...
Advertise your brand on Kalkine Media